Martin Dow Limited
TypePrivate
IndustryPharmaceutical
Founded1995 (1995)
HeadquartersKarachi, Pakistan
Key people
Jawed Akhai
(Chairman)
ProductsEnflor, Duvel Plus, Rocephin, Cal One-D, Rivotril, Musidin, Lexotanil, Inspra, Esomax, Dilatrend, Elixaban, Orpase, Dowmoxi, Safepram, Kytril, Bon One, Malcifer-F, Fusiderm, Terbin, Dormicum, Dowmoxi,Orzit,Inspra, Dowfylin, Valium
Number of employees
1,000+ [1]
SubsidiariesSeatle (Pvt.) Ltd., Martin Dow Marker, Martin Dow Healthcare, Martin Dow Pharmaceuticals
Websitewww.martindow.com
www.martindow.fr

Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi, Pakistan. It was founded in 1995[2] and is one of the leading pharmaceutical companies in Pakistan. It has more than 60 brands and over 1000 employees. Its products are manufactured in Karachi at its cGMP compliant manufacturing plant.[3]

As of 2016, Martin Dow had six manufacturing facilities in Pakistan[4] and one in France.

History

The company was founded in 1995.

In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan.[5]

In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum.[6] In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company.[7]

In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd.[8][9][10]

In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb) pharmaceutical manufacturing facility in Meymac, France.[11][12] In March 2017, the French President Francois Hollande inaugurated Martin Dow Pharma's Meymac Plant in France.[13][14] The plant of V2Pharm in Gien, France, was also taken over by Martin Dow.[15]

In 2020, Martin Dow was awarded for excellent performance in fire safety and protection by the Sindh Local Government minister.[16]

Scientific Research

In 2021, Martin Dow launched its scientific training sessions in 6 cities of Pakistan with the name of MDFIRST (Martin Dow Fellows in Research and Training). It focused on training medical post-graduate trainees on medical research writing, methodology, biostatistics and article publication skills. The aim of the program was to enhance the quality of researches generated from medical community and to equip medical professionals with knowledge that enables them to publish their quality work in national and international medical journals.[17][18][19][20]

Controversy

In 2016, the National Accountability Bureau (NAB) arrested two directors of Martin Dow because it wrongfully derived financial benefits on the basis of illegal price increase.[21][22][23]

References

  1. ↑ "CORPORATE PROFILE". Martin Dow. Retrieved 31 December 2016.
  2. ↑ "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016. Martin Dow was established in 1995 initially as a pharmaceutical marketing company in Karachi (Pakistan)
  3. ↑ "Martin Dow - Corporate Profile". Martin Dow.
  4. ↑ Hussain, Dilawar (21 November 2016). "A strategic relationship". Dawn newspaper. Retrieved 31 December 2016. With the acquisition of Merck Pakistan, Martin Dow will have six manufacturing facilities in the country.
  5. ↑ "Martin Dow - Company Profile". Business Recorder. 15 July 2012. Retrieved 28 December 2016.
  6. ↑ "List of Global Growth Company Members" (PDF). World Economic Forum. Retrieved 30 December 2016.
  7. ↑ "Treating illness: Martin Dow, Biocodex ink alliance". Express Tribune. 12 March 2015. Retrieved 2 January 2017.
  8. ↑ "German pharma giant divests interests". The Express Tribune. PPI. 8 November 2016. Retrieved 28 December 2016.
  9. ↑ "Merck divests its Pakistan stake to Martin Dow". Dawn newspaper. 8 November 2016. Retrieved 28 December 2016.
  10. ↑ "Martin Dow acquires Merck operations in Pakistan". The News International. 8 November 2016. Retrieved 28 December 2016.
  11. ↑ "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016. A Pakistani Pharmaceutical company, Martin Dow has acquired a pharmaceutical manufacturing facility in Meymac, France. The facility was earlier owned by the renowned pharmaceutical firm Bristol-Myers Squibb.
  12. ↑ Mérigaud, Corinne (3 December 2015). "Laboratoires Salem repris par le pakistanais Martin Dow". L'Usine Nouvelle. Retrieved 30 December 2016.
  13. ↑ "French President to inaugurate Pakistani Pharma Plant in France". The Nation. Retrieved 3 January 2017.
  14. ↑ "Inauguration of Martin Dow plant by the French President (Meymac, 16 March 2017)". La France au Pakistan - Ambassade de France au Pakistan. Retrieved 1 April 2019.
  15. ↑ "L'ancien site de V2Pharm à Gien va être repris". La Republique. 1 July 2015. Retrieved 3 January 2017.
  16. ↑ "Sindh LG Minister Nasir Shah gives Fire Safety Awards to 43 companies". Daily Times. 22 December 2020. Retrieved 1 January 2021.
  17. ↑ "Martin Dow conducts workshop to facilitate doctors". Daily Times. 28 September 2021. Retrieved 19 November 2021.
  18. ↑ "Martin Dow Conducts Week-long Training Program to Facilitate Doctors in Medical Research". Day News TV. 28 September 2021. Retrieved 19 November 2021.
  19. ↑ "Martin Dow conducts workshop to facilitate doctors". Martin Dow conducts workshop to facilitate doctors. Retrieved 19 November 2021.
  20. ↑ "'مارٹن ڈاؤ فرسٹ' کے عنوان سے ڈاکٹرز کے لیے ٹریننگ پروگرام کا انعقاد". UrduPoint. Retrieved 19 November 2021.
  21. ↑ "Drug business: NAB arrests 8 involved in mega corruption". The Express Tribune. 23 November 2016.
  22. ↑ "NAB arrests eight in drug price-hike cases". The Nation. 23 November 2016.
  23. ↑ "NAB arrests top bureaucrat in illegal drugs price hike case". Daily Times (Pakistan). 25 November 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.